Cargando…

Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

PURPOSE: Carbapenem-resistant Enterobacteriaceae (CRE) have been increasingly reported worldwide and pose a serious public threat, but the clinical significance of extended-spectrum β-lactamase (ESBL) production in CRE is not well established. PATIENTS AND METHODS: A retrospective case–case–control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiaolang, Sun, Shan, Jia, Xiaojiong, Zou, Hua, Li, Shuang, Zhang, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120570/ https://www.ncbi.nlm.nih.gov/pubmed/30214254 http://dx.doi.org/10.2147/IDR.S173456

Ejemplares similares

1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Bacteremia
por: Aitken, Samuel L, et al.
Publicado: (2018)

1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019)

Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Pitout, Johann DD
Publicado: (2009)

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
por: Gibble, Allison M., et al.
Publicado: (2015)

Corrigendum: Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in a Malian Orphanage
por: Tandé, Didier, et al.
Publicado: (2009)

Extended-spectrum β-Lactamase–producing Enterobacteriaceae, Central African Republic
por: Frank, Thierry, et al.
Publicado: (2006)

Extended spectrum β-lactamase producing Enterobacteriaceae & antibiotic co-resistance
por: Rudresh, S.M., et al.
Publicado: (2011)

Mother to Child Transmission of Extended Spectrum β-Lactamase Producing Enterobacteriaceae
por: Danino, Dana, et al.
Publicado: (2017)

Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021)

Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae
por: Katip, Wasan, et al.
Publicado: (2021)

Prevalence of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae in a teaching hospital in Ghana
por: Sampah, James, et al.
Publicado: (2023)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Horizontal Transfer of Antimicrobial Resistance by Extended-Spectrum β Lactamase-Producing Enterobacteriaceae
por: Vaidya, Varsha K
Publicado: (2011)

Extended-Spectrum β-Lactamase–producing Enterobacteriaceae among Travelers from the Netherlands
por: Paltansing, Sunita, et al.
Publicado: (2013)

Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
por: Guzmán-Blanco, Manuel, et al.
Publicado: (2014)

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
por: Ng, Tat Ming, et al.
Publicado: (2016)

Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems
por: Walker, Kristy J., et al.
Publicado: (2018)

Rates of Fecal Transmission of Extended-Spectrum β-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae Among Patients in Intensive Care Units in Korea
por: Kim, Jayoung, et al.
Publicado: (2014)

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
por: Joo Jung, Hyun, et al.
Publicado: (2019)

Characterization of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae From Retail Food in China
por: Ye, Qinghua, et al.
Publicado: (2018)

Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Bachtarzi, Raphaële, et al.
Publicado: (2019)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

Extended spectrum β lactamase-producing Enterobacteriaceae shedding by race horses in Ontario, Canada
por: Shnaiderman-Torban, Anat, et al.
Publicado: (2020)

Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward
por: Agostinho, Americo, et al.
Publicado: (2013)

Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an intensive care unit with no single rooms
por: Repessé, Xavier, et al.
Publicado: (2017)

Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis
por: Muhammed, Maged, et al.
Publicado: (2017)

Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae
por: Lowe, Christopher F., et al.
Publicado: (2013)

Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad
por: Ouchar Mahamat, Oumar, et al.
Publicado: (2019)

Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study
por: Mustafai, Muhammad Muqaddas, et al.
Publicado: (2023)

Drug resistance, AmpC-β-lactamase and extended-spectrum β-lactamase-producing Enterobacteriaceae isolated from fish and shrimp
por: de Almeida, Marília Viana Albuquerque, et al.
Publicado: (2017)

Analyses of Extended-Spectrum-β-Lactamase, Metallo-β-Lactamase, and AmpC-β-Lactamase Producing Enterobacteriaceae from the Dairy Value Chain in India
por: Dey, Tushar Kumar, et al.
Publicado: (2023)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon
por: Djim-Adjim-Ngana, Karyom, et al.
Publicado: (2023)

Multimodal Interventions to Prevent and Control Carbapenem-Resistant Enterobacteriaceae and Extended-Spectrum β-Lactamase Producer-Associated Infections at a Tertiary Care Hospital in Egypt
por: Kamel, Noha A., et al.
Publicado: (2021)

Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?
por: Park, Ji Young
Publicado: (2021)

Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamases and AmpC β-lactamase-Producing Enterobacteriaceae among Human, Cattle, and Poultry
por: Nossair, Mohamed A., et al.
Publicado: (2022)

Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children
por: Legese, Melese Hailu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_luo22sfjjk30ocsdbm4ed0eh7m